Guangzhou Wondfo Biotech (SHE:300482) obtained product registration from China's medical products administrator for its human microsatellite instability (MSI) detection kit.
The kit is designed for qualitative MSI testing in colorectal cancer tissue, according to a Monday filing with the Shenzhen bourse.
Shares of the biotechnology company rose 2% in recent trade.